Home > Boards > US OTC > Biotechs > DNAprint Genomics (DNAG)
Followed By 10
Posts 4644
Boards Moderated 0
Alias Born 07/10/2003

Friday, August 29, 2008 12:43:05 PM

Re: dgplexus post# 79153

Post# of 82592
Wrong again.

Second order recommendations ('a' picked 'b' and 'b' picked 'c' therefore 'a' is happy with 'c') are no different than the 'credibility by association' gambits that DNAG used before. We have been told about joint projects with Moffit, we have been told about associations with Scotland Yard, we have been told about programs with IBM, but they all amount to nothing.

Good news cannot be characterized by new and exciting partnerships. It is defined by REVENUE and nothing that you are touting is any different from what we have been hearing for years nor has it provided any revenue.

Don't judge the response to these latest nuggets of 'good news' based on your short association with the company. Those of us who have heard the boy cry wolf over and over like a stuck record are in a much better position to offer a qualified response.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y